Ionis Pharmaceuticals IONS Deferred Tax Assets Financing Arrangements
Deferred Tax Assets Financing Arrangements at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept ions:DeferredTaxAssetsFinancingArrangements.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's deferred tax assets financing arrangements.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's deferred tax assets financing arrangements?
- Ionis Pharmaceuticals (IONS) reported deferred tax assets financing arrangements of $1.31M in Q4 2025.
- What does deferred tax assets financing arrangements mean?
- Future tax savings expected from differences in how financing deals are treated for tax versus accounting purposes.
- How do you interpret deferred tax assets financing arrangements?
- An increase indicates the accumulation of future tax deductions related to financing structures.
- How does deferred tax assets financing arrangements compare across companies?
- Standard line item for companies with complex capital structures or debt financing.